Work

Abstract 291: Dual PHD2-HDAC inhibitor 31c prevents cisplatin-bevacizumab nephrotoxicity and preserves antitumor efficacy in cervical cancer.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-291

Authors: Xi Chen, Dongyu Han, Xiaohua Kong, Wenfeng Gou, Yang Song, Huiqiang Wei, Yiliang Li, Yong Qin

Institutions: The University of Texas at El Paso, Chinese Academy of Medical Sciences & Peking Union Medical College, Jinzhou Medical University

Language: English

Topic: Chemotherapy-induced organ toxicity mitigation

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148769098

Cites:

Cited by:

Related to: